BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17676877)

  • 1. Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.
    Parker ET; Lollar P
    Biochemistry; 2007 Aug; 46(34):9737-42. PubMed ID: 17676877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation.
    Parker ET; Doering CB; Lollar P
    J Biol Chem; 2006 May; 281(20):13922-30. PubMed ID: 16513639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia A mutations within the factor VIII A2-A3 subunit interface destabilize factor VIIIa and cause one-stage/two-stage activity discrepancy.
    Hakeos WH; Miao H; Sirachainan N; Kemball-Cook G; Saenko EL; Kaufman RJ; Pipe SW
    Thromb Haemost; 2002 Nov; 88(5):781-7. PubMed ID: 12428094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa.
    Pipe SW; Saenko EL; Eickhorst AN; Kemball-Cook G; Kaufman RJ
    Blood; 2001 Feb; 97(3):685-91. PubMed ID: 11157485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulant properties of hybrid human/porcine factor VIII molecules.
    Lollar P; Parker ET; Fay PJ
    J Biol Chem; 1992 Nov; 267(33):23652-7. PubMed ID: 1429706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
    Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
    J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.
    Venkateswarlu D
    BMC Struct Biol; 2010 Feb; 10():7. PubMed ID: 20184747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa.
    Gale AJ; Pellequer JL
    J Thromb Haemost; 2003 Sep; 1(9):1966-71. PubMed ID: 12941038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.
    Gale AJ; Radtke KP; Cunningham MA; Chamberlain D; Pellequer JL; Griffin JH
    J Thromb Haemost; 2006 Jun; 4(6):1315-22. PubMed ID: 16706977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of interdomain interfaces within the A3C1C2 subunit of factor VIII affects its stability and activity.
    Wakabayashi H; Fay PJ
    Biochemistry; 2013 Jun; 52(22):3921-9. PubMed ID: 23659383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo.
    Pipe SW; Eickhorst AN; McKinley SH; Saenko EL; Kaufman RJ
    Blood; 1999 Jan; 93(1):176-83. PubMed ID: 9864159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of thrombin-activated human factor VIII.
    Curtis JE; Helgerson SL; Parker ET; Lollar P
    J Biol Chem; 1994 Feb; 269(8):6246-51. PubMed ID: 8119969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit structure and function of porcine factor Xa-activated factor VIII.
    Parker ET; Pohl J; Blackburn MN; Lollar P
    Biochemistry; 1997 Aug; 36(31):9365-73. PubMed ID: 9235979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis.
    Mosesson MW; Fass DN; Lollar P; DiOrio JP; Parker CG; Knutson GJ; Hainfeld JF; Wall JS
    J Clin Invest; 1990 Jun; 85(6):1983-90. PubMed ID: 2112158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining mutations that modulate inter-subunit interactions and proteolytic inactivation enhance the stability of factor VIIIa.
    Wakabayashi H; Wintermute JM; Fay PJ
    Thromb Haemost; 2014 Jul; 112(1):43-52. PubMed ID: 24599523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen-Deuterium Exchange Mass Spectrometry Identifies Activated Factor IX-Induced molecular Changes in Activated Factor VIII.
    van Galen J; Freato N; Przeradzka MA; Ebberink EHTM; Boon-Spijker M; van der Zwaan C; van den Biggelaar M; Meijer AB
    Thromb Haemost; 2021 May; 121(5):594-602. PubMed ID: 33302303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A3 domain residue Glu1829 contributes to A2 subunit retention in factor VIIIa.
    Wakabayashi H; Zhou Q; Varfaj F; Fay PJ
    J Thromb Haemost; 2007 May; 5(5):996-1001. PubMed ID: 17371488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.
    Monaghan M; Wakabayashi H; Griffiths AE; Fay PJ
    J Thromb Haemost; 2016 May; 14(5):1021-30. PubMed ID: 26878264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing hydrophobicity or disulfide bridging at the factor VIII A1 and C2 domain interface enhances procofactor stability.
    Wakabayashi H; Griffiths AE; Fay PJ
    J Biol Chem; 2011 Jul; 286(29):25748-55. PubMed ID: 21628455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.